Quality by Design Framework Applied to GMMA Purification

  • 0GSK Vaccines Institute for Global Health (GVGH), Via Fiorentina 1, 53100, Siena, Italy. carlo.x.giannelli@gsk.com.

|

|

Summary

This summary is machine-generated.

Generalized Modules for Membrane Antigens (GMMA) offer a simple manufacturing approach for vaccines against bacterial pathogens. Implementing a quality by design framework ensures consistent production for global health initiatives.

Area Of Science

  • Vaccinology
  • Biopharmaceutical Manufacturing
  • Quality by Design

Background

  • Generalized Modules for Membrane Antigens (GMMA) are emerging as a promising vaccine platform.
  • Their manufacturing simplicity makes them particularly suitable for low- and middle-income countries.
  • Robust manufacturing is crucial for vaccine efficacy and accessibility.

Purpose Of The Study

  • To outline a Quality by Design (QbD) framework for GMMA manufacturing.
  • To identify critical quality attributes (CQAs) and process parameters for GMMA production.
  • To support the development and control of GMMA-based vaccine manufacturing processes.

Main Methods

  • Application of QbD principles to GMMA production.
  • Assessment of critical quality attributes (CQAs).
  • Analysis of product-process interactions and in-process analytical methods.

Main Results

  • A systematic methodology for QbD implementation in GMMA manufacturing is proposed.
  • The approach facilitates the control of manufacturing processes for consistent batch characteristics.
  • Initial steps of GMMA manufacturing process were analyzed using the suggested methodology.

Conclusions

  • QbD implementation is essential for robust GMMA manufacturing.
  • This framework supports technical transfer, regulatory approval, and commercialization of GMMA vaccines.
  • The presented methodology aids in ensuring the quality and consistency of GMMA-based vaccines.